METASTATIC KIDNEY CARCINOMA
Clinical trials for METASTATIC KIDNEY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC KIDNEY CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC KIDNEY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy zaps spine tumors before they paralyze
Disease control OngoingThis study tests a combination of two treatments—heat-based tumor destruction (thermal ablation) and precise high-dose radiation (stereotactic radiosurgery)—for people whose cancer has spread to the spine and is pressing on the spinal cord. The goal is to control the tumor and pr…
Matched conditions: METASTATIC KIDNEY CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 02:07 UTC
-
New drug cocktail shows promise against tough kidney cancer
Disease control OngoingThis study tests a combination of two drugs—entinostat and aldesleukin—for people with kidney cancer that has spread. The goal is to find the safest dose and see if the combo can shrink tumors. About 47 adults with clear cell kidney cancer are taking part.
Matched conditions: METASTATIC KIDNEY CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New immunotherapy cocktail shows promise for advanced kidney cancer
Disease control OngoingThis early-phase study tests whether giving immunotherapy drugs (nivolumab alone or with bevacizumab or ipilimumab) before surgery is safe for people with kidney cancer that has spread. About 104 participants will receive these treatments to see how the body reacts and whether th…
Matched conditions: METASTATIC KIDNEY CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:51 UTC